ClinicalTrials.gg
SuspendedNCT05793879Aphasia360Updated Mar 19, 2026

Virtual Reality Training for Aphasia Rehabilitation

An interventional study of Video 360 and Standard videos in Anomic Aphasia, sponsored by Catholic University of the Sacred Heart. Suspended at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Catholic University of the Sacred Heart · Not applicable, Interventional, and Treatment

Why this study was suspended
No more opportunities to recruit patients
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Aphasia is an acquired deficit following acute damage to the central nervous system that involves the difficulty or impossibility of understanding and formulating language. A typical disorder of non-fluent forms of aphasia is anomia. Anomia refers to the difficulty in finding words, in particular when trying to name objects and actions. According to the Embodied Cognition approach (EC), language is tightly connected to the motor system. In this view, language rehabilitation programs should stimulate language through the activation of the motor system. In this approach, since anomic deficits are often due to a weak link between the meaning of the word and its lemma, the Hebbs' principles of coincident and correlated learning can be exploited, i.e., by intensifying the synchronous activation of lexicon and semantics and connecting them with the motor counterpart. In this study, the investigators present an innovative training, based on the EC framework, in which they will make use of new technologies for anomia rehabilitation in post-stroke patients. Specifically, the researchers will use immersive 360° videos representing everyday actions displayed from the first-person point of view, experienced through a head-mounted display. The training will be administered 3 times a week for 4 weeks. The control group will watch standard videos representing the same actions recorded from the third-person perspective. Naming abilities will be tested before and after the training together with other cognitive and psychological measures. The investigators expect that the group who will undergo the 360° video-based training will show greater improvement of performance compared to the control group.

02

Conditions studied

  • Anomic Aphasia

Browse trials for

Keywords

  • virtual reality
  • embodied cognition
  • rehabilitation
03

In context

Anomia

47 studies on the registry are indexed under Anomia; 9 are open to participants now.

This study's planned enrollment of 40 is above the median of 24 across 43 interventional studies indexed under Anomia.

Browse Anomia studies →

Lead sponsor

Catholic University of the Sacred Heart is the lead sponsor of 237 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • naming disorder in the post-acute phase (index event occurring at least 6 months earlier)
  • to have already received rehabilitation treatment in the acute phase
  • noun naming below cut-off
  • verbs naming below cut- off

Exclusion criteria

Exclusion Criteria:

  • concomitant or pre-existing (with respect to the index event) neurological and psychiatric deficits
  • epilepsy
  • balance disorders
  • neglect
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Video 360

    Patients will watch spherical videos displaying everyday actions towards objects; an audio is embedded describing the action and the object represented (i.e. "I'm cutting the potatoes").

    Behavioral: Video 360

  • Active comparator
    Standard video

    Patients will watch standard videos displaying everyday actions towards objects; an audio is embedded describing the action and the object represented (i.e. "I'm cutting the potatoes")

    Behavioral: Standard videos

Interventions

  • BehavioralVideo 360

    Patients will undergo 12 sessions, 3 per weeks, 4 weeks

  • BehavioralStandard videos

    Patients will undergo 12 sessions, 3 per weeks, 4 weeks

06

What researchers measure

Primary outcomes

  1. Number of verbs and objects correctly named

    All the trained videos will be presented and the patient will be asked to name the verb and the object depicted. The accuracy will be registered

    Time frame: post treatment, 1 month

Secondary outcomes

  1. Batteria per l'Analisi dei Deficit Afasici (BADA), naming subtest

    It is an Italian validated neuropsychological battery aiming at testing all the language abilities. It includes several tests tapping into the different linguistic abilities, but for the purpose of the present study only the verb and object naming subtest will be administered. Higher scores indicate greater naming abilities

    Time frame: post treatment, 1 month

  2. EuroQol Health-related quality of life (EQ-5D-3L)

    The test consists of 2 sections. The first one is made of 5 questions scored from 1 to 5 points each. The final score ranges from 5 to 15, where the lesser the better. The second section is a visual scale on which the best state the patient can imagine is marked 100 and the worst state is marked 0.

    Time frame: post treatment, 1 month

  3. Functional Outcome Questionnaire (FOQ-A)

    The survey is administered to the caregiver. It includes 32 questions each scored from 1 to 5 points. The final scores ranges from 32 to 160, where higher scores indicate greater communication abilities

    Time frame: post treatment, 1 month

07

Study locations

1 site
  • Poliambulanza
    Brescia, Brescia 25123, Italy
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2023 to primary completion in Dec 2025, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2023
First posted
Mar 31, 2023
StartActual
May 2, 2023
Primary completionActual
Dec 31, 2025
CompletionEst.
Mar 2026
Last update
Mar 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05793879
Collaborators
Fondazione Poliambulanza
Responsible party
Claudia Repetto (Associate Professor, Catholic University of the Sacred Heart) — Principal investigator
First posted
Mar 31, 2023
Start date
May 2, 2023
Primary completion
Dec 31, 2025
Completion
Mar 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Claudia Repetto, Prof
principal investigator · Catholic University of the Sacred Heart

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is suspended, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion